NU7441 (KU-57788)

For research use only. Not for use in humans.

目录号：S2638

CAS No. 503468-95-9

NU7441 (KU-57788)是一种高度有效的，选择性DNA-PK抑制剂，在无细胞试验中IC50为14 nM，也会抑制 mTOR 和 PI3K，对应的IC50值分别为1.7 μM和5 μM。它可降低NHEJ的频率，而增强Cas9介导DNA剪接后发生的同源重组修复率。

规格

价格

库存

购买数量

10mM (1mL in DMSO)	RMB 922.34	现货
5mg	RMB 565.91	现货
50mg	RMB 3040.41	现货
200mg	RMB 7928.18	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达全国免运费分装免费

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的NU7441 (KU-57788)发表文献196篇：

Cell Metab, 2022, S1550-4131(21)00542-8

PubMed: 35021043 ( click the link to review the publication )

Immunity, 2021, S1074-7613(21)00069-8

PubMed: 33667382 ( click the link to review the publication )

Cell Res, 2021, 10.1038/s41422-021-00528-3

PubMed: 34239070 ( click the link to review the publication )

Nature, 2020, 10.1038/s41586-020-2960-y

PubMed: 33239783 ( click the link to review the publication )

Nature, 2019, 74(7779):571-574

PubMed: 31645724 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2018, 34(3):396-410

PubMed: 30205044 ( click the link to review the publication )

Nat Biotechnol, 2017, 35(5):463-474

PubMed: 28319085 ( click the link to review the publication )

EMBO Mol Med, 2022, e14501

PubMed: 35107878 ( click the link to review the publication )

Clin Cancer Res, 2022, clincanres.1846.2021

PubMed: 35078861 ( click the link to review the publication )

Cell Rep, 2022, 38(7):110396

PubMed: 35172151 ( click the link to review the publication )

Sci Signal, 2022, 15(725):eabh1121

PubMed: 35290083 ( click the link to review the publication )

NPJ Breast Cancer, 2022, 8(1):31

PubMed: 35273179 ( click the link to review the publication )

Virulence, 2022, 13(1):241-257

PubMed: 35067196 ( click the link to review the publication )

FASEB J, 2022, 36(3):e22221

PubMed: 35199383 ( click the link to review the publication )

Phytomedicine, 2022, 99:153977

PubMed: 35305353 ( click the link to review the publication )

Genesis, 2022, 60(1-2):e23465

PubMed: 35072325 ( click the link to review the publication )

NAR Cancer, 2022, 4(2):zcac012

PubMed: 35425901 ( click the link to review the publication )

Sci Transl Med, 2021, 13(600)eabc7275

PubMed: 34193614 ( click the link to review the publication )

Sci Transl Med, 2021, 13(587)eabg1168

PubMed: 33790022 ( click the link to review the publication )

Sci Adv, 2021, 7(25)eabg6680

PubMed: 34144993 ( click the link to review the publication )

Nat Commun, 2021, 12(1):6561

PubMed: 34772932 ( click the link to review the publication )

Nat Commun, 2021, 12(1):6560

PubMed: 34772923 ( click the link to review the publication )
J Clin Invest, 2021, 131(11)146256

PubMed: 34060485 ( click the link to review the publication )

Nucleic Acids Res, 2021, gkab262

PubMed: 33877327 ( click the link to review the publication )

Nucleic Acids Res, 2021, gkab743

PubMed: 34428289 ( click the link to review the publication )

Nucleic Acids Res, 2021, 49(9):5095-5105

PubMed: 33963863 ( click the link to review the publication )

Cell Rep, 2021, 37(2):109815

PubMed: 34644577 ( click the link to review the publication )

Protein Cell, 2021, 10.1007/s13238-021-00879-y 10.1126/science.abc5386

PubMed: 34676498 ( click the link to review the publication )

Cell Mol Gastroenterol Hepatol, 2021, S2352-345X(21)00249-6

PubMed: 34896285 ( click the link to review the publication )

J Exp Clin Cancer Res, 2021, 40(1):224

PubMed: 34225780 ( click the link to review the publication )

JCI Insight, 2021, e154402

PubMed: 34932500 ( click the link to review the publication )

Cancers (Basel), 2021, 13(4)830

PubMed: 33669398 ( click the link to review the publication )

Sci Signal, 2021, 14(705):eabc4764

PubMed: 34665642 ( click the link to review the publication )

Int J Biol Sci, 2021, 17(4):1026-1040

PubMed: 33867826 ( click the link to review the publication )

Int J Biol Sci, 2021, 17(4): 1026-1040

PubMed: N/A ( click the link to review the publication )

Int J Mol Sci, 2021, 22(19)10512

PubMed: 34638853 ( click the link to review the publication )

FEBS J, 2021, 10.1111/febs.16321

PubMed: 34914197 ( click the link to review the publication )

Mol Cancer Res, 2021, molcanres.0301.2021

PubMed: 34330845 ( click the link to review the publication )

Acta Pharmacol Sin, 2021, 10.1038/s41401-020-00577-1

PubMed: 33414509 ( click the link to review the publication )

Cell Signal, 2021, S0898-6568(21)00195-9

PubMed: 34363951 ( click the link to review the publication )

Med Phys, 2021, 48(6):3243-3261

PubMed: 33837540 ( click the link to review the publication )

Biochem Biophys Res Commun, 2021, 553:51-57

PubMed: 33756345 ( click the link to review the publication )

Mol Biol Rep, 2021, 10.1007/s11033-020-06124-9

PubMed: 33389482 ( click the link to review the publication )

FEBS Open Bio, 2021, 10.1002/2211-5463.13198

PubMed: 33999508 ( click the link to review the publication )

Commun Biol, 2021, 4(1):484

PubMed: 33875784 ( click the link to review the publication )

Sci Transl Med, 2021, 13(580)eabc4465

PubMed: 33568520 ( click the link to review the publication )
Nucleic Acids Res, 2021, gkab051

PubMed: 33591315 ( click the link to review the publication )

Blood, 2020, 5 pii: blood

PubMed: 32369572 ( click the link to review the publication )

Adv Sci (Weinh), 2020, 7(20):2000157

PubMed: 33101843 ( click the link to review the publication )

Mol Cell, 2020, S1097-2765(20)30723-1

PubMed: 33152268 ( click the link to review the publication )

Nat Commun, 2020, 11(1):6182

PubMed: 33273464 ( click the link to review the publication )

Nat Commun, 2020, 11(1):5775

PubMed: 33188175 ( click the link to review the publication )

Nucleic Acids Res, 2020, 10.1093/nar/gkaa022

PubMed: 31965183 ( click the link to review the publication )

Nucleic Acids Res, 2020, gkaa782

PubMed: 33010172 ( click the link to review the publication )

Sci Immunol, 2020, 5(43)

PubMed: 31980485 ( click the link to review the publication )

Clin Cancer Res, 2020, 10.1158/1078-0432.CCR-20-2269

PubMed: 32967938 ( click the link to review the publication )

J Cell Biol, 2020, 219(11)e202001063

PubMed: 33007086 ( click the link to review the publication )

Cell Rep, 2020, 32(8):108068

PubMed: 32846126 ( click the link to review the publication )

Cell Rep, 2020, 32(11):108140

PubMed: 32937135 ( click the link to review the publication )

Cell Rep, 2020, 33(2):108240

PubMed: 33053351 ( click the link to review the publication )

Signal Transduct Target Ther, 2020, 4;5(1):20

PubMed: 32296021 ( click the link to review the publication )

Mol Oncol, 2020, 26

PubMed: 32336009 ( click the link to review the publication )

Mol Cancer Res, 2020, 10.1158/1541-7786.MCR-19-0507

PubMed: 32229503 ( click the link to review the publication )

Front Oncol, 2020, 10:575711

PubMed: 33178606 ( click the link to review the publication )

Int J Mol Sci, 2020, 21(17)E6383

PubMed: 32887472 ( click the link to review the publication )

Int J Oncol, 2020, 57(4):939-955

PubMed: 32945394 ( click the link to review the publication )

Int J Radiat Biol, 2020, 1-7

PubMed: 33074046 ( click the link to review the publication )

J Cell Physiol, 2020, 10.1002/jcp.29927

PubMed: 32686190 ( click the link to review the publication )

Nucleic Acids Res, 2020, 48(2):736-747

PubMed: 31740976 ( click the link to review the publication )

University of Lübeck, 2020, N/A

PubMed: None ( click the link to review the publication )
Cancers (Basel), 2020, 12(9):E2356

PubMed: 32825402 ( click the link to review the publication )

Cancers (Basel), 2020, 12(6):1490

PubMed: 32517381 ( click the link to review the publication )

Oncotarget, 2020, 11(7):699-726

PubMed: 32133046 ( click the link to review the publication )

NAR Cancer, 2020, 2(2):zcaa006

PubMed: 32743550 ( click the link to review the publication )

Elife, 2020, 9:e57894

PubMed: 32628111 ( click the link to review the publication )

J Biol Chem, 2020, 295(1):125-137

PubMed: 31753920 ( click the link to review the publication )

Int J Mol Med, 2020, 45(6):1673-1684

PubMed: 32186748 ( click the link to review the publication )

Cell Rep, 2020, 32(6):108018

PubMed: 32783940 ( click the link to review the publication )

Toxicol Lett, 2020, 318:104-113

PubMed: 31672611 ( click the link to review the publication )

Biomed Pharmacother, 2020, 129:110427

PubMed: 32574974 ( click the link to review the publication )

Nat Commun, 2019, 10(1):5304

PubMed: 31757956 ( click the link to review the publication )

Nat Commun, 2019, 10(1):1577

PubMed: 30952868 ( click the link to review the publication )

Nat Commun, 2019, 10(1):3925

PubMed: 31477700 ( click the link to review the publication )

Nat Commun, 2019, 10(1):2866

PubMed: 31253785 ( click the link to review the publication )

Clin Cancer Res, 2019, 25(18):5608-5622

PubMed: 31266829 ( click the link to review the publication )

Genes Dev, 2019, 33(17-18):1175-1190

PubMed: 31395742 ( click the link to review the publication )

Haematologica, 2019, 104(11):2225-2240

PubMed: 30819918 ( click the link to review the publication )

J Cell Biol, 2019, 218(7):2113-2123

PubMed: 31123184 ( click the link to review the publication )

Cell Rep, 2019, 29(11):3708-3725.e5

PubMed: 31825846 ( click the link to review the publication )

Int J Cancer, 2019, 10.1002/ijc.32558

PubMed: 31283004 ( click the link to review the publication )

Oncogene, 2019, 38(14):2451-2463

PubMed: 30532030 ( click the link to review the publication )

Cancers (Basel), 2019, 11(9)

PubMed: 31480356 ( click the link to review the publication )

Br J Cancer, 2019, 121(7):600-610

PubMed: 31481733 ( click the link to review the publication )

FASEB J, 2019, 33(1):1138-1150

PubMed: 30106602 ( click the link to review the publication )
FASEB J, 2019, 33(11):11668-11681

PubMed: 31348687 ( click the link to review the publication )

FASEB J, 2019, 33(6):6778-6788

PubMed: 30807703 ( click the link to review the publication )

PLoS Genet, 2019, 15(2):e1007925

PubMed: 30716077 ( click the link to review the publication )

J Environ Manage, 2019, 244:77-82

PubMed: 31108313 ( click the link to review the publication )

Mol Cancer Res, 2019, 17(12):2457-2468

PubMed: 31551253 ( click the link to review the publication )

Toxicol Sci, 2019, 10.1093/toxsci/kfz178

PubMed: 31388677 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(24)E6316

PubMed: 31847370 ( click the link to review the publication )

J Biol Chem, 2019, 294(8):2827-2838

PubMed: 30598506 ( click the link to review the publication )

Mol Cell Biol, 2019, 39(24)e00181-19

PubMed: 31591143 ( click the link to review the publication )

J Pharmacol Exp Ther, 2019, 371(2):320-326

PubMed: 31455631 ( click the link to review the publication )

Retrovirology, 2019, 16(1):13

PubMed: 31036006 ( click the link to review the publication )

Front Physiol, 2019, 10:616

PubMed: 31178753 ( click the link to review the publication )

BMC Pulm Med, 2019, 19(1-:165

PubMed: 31464599 ( click the link to review the publication )

Mol Biol Rep, 2019, 10.1007/s11033-019-04605-0

PubMed: 31020489 ( click the link to review the publication )

Mol Biol Rep, 2019, 10.1007/s11033-019-05105-x

PubMed: 31583565 ( click the link to review the publication )

Mol Med Rep, 2019, 20(4):3609-3616

PubMed: 31485633 ( click the link to review the publication )

FEBS Open Bio, 2019, 9(7):1315-1326

PubMed: 31141305 ( click the link to review the publication )

Nucleic Acids Res, 2019, 47(21):10977-10993

PubMed: 31612207 ( click the link to review the publication )

Nucleic Acids Res, 2019, 47(18):9467-9479

PubMed: 31396623 ( click the link to review the publication )

Nucleic Acids Res, 2019, 47(16):8838-8859

PubMed: 31329944 ( click the link to review the publication )

Cell Res, 2018, 28(7):756-770

PubMed: 29844578 ( click the link to review the publication )

Nat Commun, 2018, 9(1):5351

PubMed: 30559436 ( click the link to review the publication )

Cell Rep, 2018, 24(4):987-1000

PubMed: 30044993 ( click the link to review the publication )

Int J Cancer, 2018,

PubMed: 29363109 ( click the link to review the publication )
Cell Death Dis, 2018, 9(9):931

PubMed: 30209297 ( click the link to review the publication )

FASEB J, 2018, 32(4):1818-1829

PubMed: 29162700 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2551-2563

PubMed: 30217967 ( click the link to review the publication )

Hum Mol Genet, 2018, 27(23):4024-4035

PubMed: 30107443 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(3):428-438

PubMed: 29222170 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(8):1241-1254

PubMed: 29739874 ( click the link to review the publication )

DNA Repair (Amst), 2018, 68:12-24

PubMed: 29807321 ( click the link to review the publication )

DNA Repair (Amst), 2018, 68:68-74

PubMed: 30017059 ( click the link to review the publication )

Mol Biol Cell, 2018, 29(15):1786-1797

PubMed: 29897835 ( click the link to review the publication )

Int J Mol Sci, 2018,

PubMed: 30115874 ( click the link to review the publication )

Sci Rep, 2018, 8(1):9685

PubMed: 29946146 ( click the link to review the publication )

Nucleic Acids Res, 2018, 46(10):5050-5060

PubMed: 29660033 ( click the link to review the publication )

Nucleic Acids Res, 2018, 46(17):8926-8939

PubMed: 30113698 ( click the link to review the publication )

Sci Rep, 2018, 8(1):14421

PubMed: 30258062 ( click the link to review the publication )

Biochem Biophys Rep, 2018, 16:115-121

PubMed: 30417129 ( click the link to review the publication )

Oncotarget, 2018, 9(9):8560-8572

PubMed: 29492217 ( click the link to review the publication )

JCI Insight, 2018, 3(3)98096

PubMed: 29415883 ( click the link to review the publication )

Nucleic Acids Res, 2017, 45(1):244-254

PubMed: 28069995 ( click the link to review the publication )

Cancer Immunol Res, 2017, 5(9):790-803

PubMed: 28775208 ( click the link to review the publication )

Cancer Res, 2017, 77(17):4567-4578

PubMed: 28698210 ( click the link to review the publication )

Cancer Res, 2017, 77(18):4745-4754

PubMed: 28754673 ( click the link to review the publication )

J Cell Biol, 2017, 216(3):623-639

PubMed: 28228534 ( click the link to review the publication )

EMBO Rep, 2017, 18(8):1412-1428

PubMed: 28615293 ( click the link to review the publication )

Cell Death Discov, 2017, 3:17072

PubMed: 29090098 ( click the link to review the publication )
J Biol Chem, 2017, 292(30):12424-12435

PubMed: 28592488 ( click the link to review the publication )

Mol Biol Cell, 2017, 28(26):3756-3772

PubMed: 29074567 ( click the link to review the publication )

Int J Biochem Cell Biol, 2017, 92:164-172

PubMed: 28827033 ( click the link to review the publication )

Radiat Res, 2017, 188(6):597-604

PubMed: 28952912 ( click the link to review the publication )

PLoS One, 2017, 12(7):e0181608

PubMed: 28750002 ( click the link to review the publication )

DNA Repair (Amst), 2017, 54:30-39

PubMed: 28448822 ( click the link to review the publication )

Oncotarget, 2017, 8(52):90037-90049

PubMed: 29163809 ( click the link to review the publication )

Oncotarget, 2017, 8(2):2916-2935

PubMed: 27935866 ( click the link to review the publication )

Nat Cell Biol, 2016, 18(11):1196-1207

PubMed: 27723717 ( click the link to review the publication )

blood, 2016, 10.1182/blood-2016-02-700328

PubMed: ( click the link to review the publication )

Blood, 2016, 128(4):574-83

PubMed: 27235137 ( click the link to review the publication )

Nat Commun, 2016, 7:12880

PubMed: 27634057 ( click the link to review the publication )

Oncogene, 2016, 35(5):577-586

PubMed: 25893305 ( click the link to review the publication )

Cancer Lett, 2016, 383(1):41-52

PubMed: 27693461 ( click the link to review the publication )

Cell Death Dis, 2016, 7(7):e2316

PubMed: 27468692 ( click the link to review the publication )

Sci Rep, 2016, 6:22972

PubMed: 27026501 ( click the link to review the publication )

Cell Cycle, 2016, 15(1):84-94

PubMed: 26771713 ( click the link to review the publication )

PLoS One, 2016, 11(12):e0167454

PubMed: 27907109 ( click the link to review the publication )

PLoS One, 2016, 11(5):e0155230

PubMed: 27153109 ( click the link to review the publication )

PLoS One, 2016, 11(9):e0163049

PubMed: 27643854 ( click the link to review the publication )

Nucleic Acids Res, 2016, 44(11):5204-17

PubMed: 27001513 ( click the link to review the publication )

Oncotarget, 2016, 7(38):60807-60822

PubMed: 27602502 ( click the link to review the publication )

Nucleic Acids Res, 2016, 44(8):3695-712

PubMed: 26843428 ( click the link to review the publication )

Oncotarget, 2016, 7(40):65504-65513

PubMed: 27602767 ( click the link to review the publication )
Mutat Res Genet Toxicol Environ Mutagen, 2016, 795:1-6

PubMed: 26774662 ( click the link to review the publication )

Nat Cell Biol, 2015, 17(9):1158-68

PubMed: 26237645 ( click the link to review the publication )

Leukemia, 2015, 29(5):1133-42

PubMed: 25371178 ( click the link to review the publication )

Genome Med, 2015, 10.1186/s13073-015-0215-6

PubMed: 26307031 ( click the link to review the publication )

Mol Cancer Ther, 2015, 14(8):1896-906

PubMed: 26026052 ( click the link to review the publication )

Mol Cancer Res, 2015, 13(1):120-9

PubMed: ( click the link to review the publication )

Mol Cancer Res, 2015, 13(1):120-9

PubMed: 25232030 ( click the link to review the publication )

J Biol Chem, 2015, 290(46):27545-56

PubMed: 26420486 ( click the link to review the publication )

Cancer Biol Ther, 2015, 16(11):1585-92

PubMed: 26382920 ( click the link to review the publication )

Cell Cycle, 2015, 14(23):3713-24

PubMed: 26505547 ( click the link to review the publication )

PLoS ONE, 2015,

PubMed: 26065416 ( click the link to review the publication )

Anticancer Res, 2015, 35(7):3829-38

PubMed: 26124328 ( click the link to review the publication )

Oncotarget, 2015, 6(16):14005-25

PubMed: 26087309 ( click the link to review the publication )

Nucleic Acids Res, 2014, 42(12):7776-92

PubMed: 24906880 ( click the link to review the publication )

Nucleic Acids Res, 2014, 42(9):5616-32

PubMed: 24598253 ( click the link to review the publication )

Genes Dev, 2014, 28(8):875-87

PubMed: 24700029 ( click the link to review the publication )

Cancer Res, 2014, 74(16):4282-94

PubMed: 24894717 ( click the link to review the publication )

Oncogene, 2014, 10.1038/onc.2014.268

PubMed: 25132265 ( click the link to review the publication )

ACS Chem Biol, 2014, 9(5):1160-71

PubMed: 24568369 ( click the link to review the publication )

Toxicol Sci, 2014, 10.1093/toxsci/kfu207

PubMed: 25288669 ( click the link to review the publication )

Biosci Rep, 2014, 34(3)

PubMed: 24844881 ( click the link to review the publication )

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014,

PubMed: ( click the link to review the publication )

Uppsala University, 2014, Department of Radiology

PubMed: ( click the link to review the publication )

Mutat Res, 2014, 769:1-10

PubMed: 25771720 ( click the link to review the publication )
Nucleic Acids Res, 2013, 41(22):10157-69

PubMed: 24021630 ( click the link to review the publication )

Nucleic Acids Res, 2013, 41(7):4080-92

PubMed: 23449221 ( click the link to review the publication )

Nucleic Acids Res, 2013, 41(15):7378-86

PubMed: 23775790 ( click the link to review the publication )

Int J Radiat Oncol Biol Phys, 2013, 88(2):385-94

PubMed: 24411611 ( click the link to review the publication )

产品安全说明书

DNA-PK抑制剂选择性比较

生物活性

产品描述

靶点

DNA-PK ^[1] (Cell-free assay)	mTOR ^[1] (cell-free assay)	PI3K ^[1] (cell-free assay)
14 nM	1.7 μM	5 μM

体外研究

NU7441抑制DNA依赖性蛋白激酶 (DNA-PK) 比抑制其他PI3K相关激酶 (PIKK)家族成员选择性高，IC50 为14 nM。^[1] 电离辐射诱导或Etoposide诱导 DNA 损伤后，1 μM NU7441提高γH2AX病灶的持久性。NU7441 浓度为 0.5 μM 或 1 μM时，作用于SW620 和 LoVo细胞，显著提高电离辐射，Etoposide, 和 Doxorubicin 诱导的G2-M累积增多。^[2] NU7441浓度为1 μM时，引起 Doxorubicin和电离辐射诱导的DNA双链断裂的持久性，也稍微降低同源重组活性 DNA-PK充足的 M059-Fus-1和 DNA-PK缺陷的 M059 J人类肿瘤细胞。^[3] NU7441浓度为 10 μM 时，作用于缺乏和表达polη的细胞，抑制UV诱导 RPA p34过度磷酸化。^[4] NU7441 浓度为1 μM时，作用于慢性淋巴细胞性白血病细胞。提高Fludarabine诱导的γH2AX病灶水平，也相应地降低Fludarabine诱导的细胞死亡。^[5] NU7441浓度为 1 μM时，作用于慢性淋巴细胞性白血病细胞，抑制Mitoxantrone诱导的DNA-PKcs自磷酸化和修复。^[6]它可降低NHEJ的频率，而增强Cas9介导DNA剪接后发生的同源重组修复率 ^[7]。

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Activity Description	PMID
NCI-H1770	M3LJO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NUnVdJdPUUN3ME2wMlAzOTR\|IN88US=>	M2i0cFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
A172	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NEWxfXZKSzVyPUCuNVU{OTZizszN	NV7BeXFiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H526	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MnizTWM2OD1yLkK4OFA4KM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HDLM-2	M4nYOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MYLJR\|UxRTBwM{KzOFUh\|ryP	NUjT[Y1zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HuO-3N1	M2HibWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			Mmf6TWM2OD1yLkS2OlM3KM7:TR?=	MnW5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-SNU-1	NX61cWplT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M2DMVmlEPTB;MD62NFk6PCEQvF2=	MorNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SK-N-AS	MkLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MlPpTWM2OD1yLk[yNlE3KM7:TR?=	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LoVo	MnPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MoCzTWM2OD1yLki2O\|Q6KM7:TR?=	M1e3flxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LAMA-84	M3TrdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MW\JR\|UxRTBwOUi4N\|Mh\|ryP	NU\lTYlCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
CTB-1	NV3mUWE1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NYnvOWw4UUN3ME2xMlEyPTR4IN88US=>	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KP-N-YS	Mn:yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MYfJR\|UxRTFwMUSyN\|Eh\|ryP	MnXCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
HH	NEnndGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NYDJWFFOUUN3ME2xMlE5ODl\|IN88US=>	Mmn3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
CHL-1	NWWw[GJDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NGOycJRKSzVyPUGuNlE{PjhizszN	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NB7	NHLt[nhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M4PXNmlEPTB;MT6yOFc1PSEQvF2=	NYfkdllmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HL-60	MmLJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NGGx[otKSzVyPUGuN\|gyQSEQvF2=	NHLTSWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
639-V	M2fTS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MYTJR\|UxRTFwNESxNlgh\|ryP	NHjlTHU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
NCI-H1793	M1zHUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M3fxPGlEPTB;MT60OVg1KM7:TR?=	NVm3ZW9nRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NEC8	NIXVe4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MXfJR\|UxRTFwNUWzOUDPxE1?	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
PA-1	NHrQdmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MmDXTWM2OD1zLkW4Nlk1KM7:TR?=	M17TXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
D-423MG	NULtSI17T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mn20TWM2OD1zLk[5N\|YyKM7:TR?=	M{jmO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
NCI-H292	M333[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M{PZeGlEPTB;MT63OFAyOyEQvF2=	NWnWcFZHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
SK-MEL-1	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NYHOcXBuUUN3ME2xMlc6PDd7IN88US=>	M17HU\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LB2241-RCC	NXrZbIk4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MV;JR\|UxRTJwMUSxOFYh\|ryP	NIHKRo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SK-MEL-3	NX;PRlJJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mlz0TWM2OD1{LkG2OFkh\|ryP	M2fLVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
MHH-PREB-1	NVrMfoE1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M3ixfGlEPTB;Mj6xOlYxQSEQvF2=	NYnYdFduRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
BFTC-905	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NH;YVo1KSzVyPUKuNVY3QDdizszN	MkTJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
Ramos-2G6-4C10	M1;MXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M2ftS2lEPTB;Mj6xPVkxQSEQvF2=	MlnhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
G-361	MlTWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MnLETWM2OD1{LkKxOlgh\|ryP	NXTZWphSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MOLT-4	Mme0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NIrHVHNKSzVyPUKuNlE5QDhizszN	NHPX[nQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
DEL	NFnVN2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MmLBTWM2OD1{LkO1OVY1KM7:TR?=	MoTDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
MV-4-11	M3jGemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NXm4PY1SUUN3ME2yMlM4OzlizszN	NWXYW4RXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
SK-NEP-1	NXLQW4tNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MX3JR\|UxRTJwM{i3PFMh\|ryP	NELiSFA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
RS4-11	M{HySGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MlXUTWM2OD1{LkW2NFI{KM7:TR?=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HuH-7	Ml;US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NUTkU3k6UUN3ME2yMlU3PzB{IN88US=>	NXWwOlVmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
A101D	NYDaXJQxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MUPJR\|UxRTJwNkGzN\|gh\|ryP	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KG-1	Ml;lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MkLBTWM2OD1{Lk[3PVI1KM7:TR?=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KALS-1	M13OUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M{jiV2lEPTB;Mj62PVY{OyEQvF2=	NILHVnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
VMRC-RCZ	NVTJflJrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M1zSN2lEPTB;Mj63O\|MzQCEQvF2=	NYjucJYyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
SK-UT-1	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MkTPTWM2OD1\|LkG1N\|Eh\|ryP	MnX6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SW962	MoTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWXJR\|UxRTNwMkCzOVIh\|ryP	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
DBTRG-05MG	NX;lXVVOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NFnOcHJKSzVyPUOuNlgxQDVizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
PANC-08-13	NGfoboJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NEe1bZZKSzVyPUOuOFEzPzhizszN	NIPwUZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
QIMR-WIL	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MWnJR\|UxRTNwNEGzOFEh\|ryP	MmGzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SK-MEL-30	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NHLmS3dKSzVyPUOuOFI2QThizszN	NHK2VmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
697	Mn2zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			Mn75TWM2OD1\|LkS0PVk{KM7:TR?=	MkX3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NY	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MmTRTWM2OD1\|LkS1NFIzKM7:TR?=	NYnUN2loRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
ES7	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MUXJR\|UxRTNwNE[3Nlkh\|ryP	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
JVM-3	NIXJN2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NEnHRpdKSzVyPUOuOFgxPzdizszN	MoPLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
U031	NXi1To9DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mom2TWM2OD1\|LkW5N\|Y5KM7:TR?=	M4nnVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
BHT-101	M1LqZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MV7JR\|UxRTNwNUm5PFUh\|ryP	M4LuTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
8305C	NWjrcpRuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NHvNXnhKSzVyPUOuOlE4OzZizszN	NWfZVnlTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MG-63	NUSxTIg3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MYLJR\|UxRTNwNkK2O\|Yh\|ryP	NHmwdWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
NOS-1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NF\DT3NKSzVyPUOuOlU{OTJizszN	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
YH-13	NV\sSZBuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M1jBb2lEPTB;Mz64O\|E5QSEQvF2=	M3j6e\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LXF-289	M1Xk[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M{jZO2lEPTB;Mz65NVA1OSEQvF2=	M3HPO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
GOTO	MonoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M3vOV2lEPTB;Mz65NVQ6KM7:TR?=	M4fTOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
EKVX	M4HjTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmHaTWM2OD12LkKyOVI1KM7:TR?=	NGrQW2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
CAL-51	MmPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHnVS2ZKSzVyPUSuNlQ5PTRizszN	NVHqdVBVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
AN3-CA	NVfFZ5R4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MU\JR\|UxRTRwMkW4NVMh\|ryP	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
IA-LM	MlzlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			Mnv5TWM2OD12LkK3PVM2KM7:TR?=	M2W0[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
KU-19-19	NWrFR2xmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M2exdGlEPTB;ND6zNlkzOSEQvF2=	MlXWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
A704	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M4q1OmlEPTB;ND60NFg5QCEQvF2=	M4fYd\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
RH-18	M37lPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NVvSNW5VUUN3ME20MlQ1QTV\|IN88US=>	NVPHTFhyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
IST-MEL1	MnTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MVnJR\|UxRTRwNUiyOlMh\|ryP	NX3QNo5kRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
LU-134-A	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MV3JR\|UxRTRwNUm2PFUh\|ryP	M2fGfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SF126	MnXrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MVfJR\|UxRTRwNkC3NVUh\|ryP	Mke5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
EFO-27	NYTkdHlyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mn;5TWM2OD12Lk[2OVI2KM7:TR?=	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
SN12C	M3\WZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MU\JR\|UxRTRwN{G4PVgh\|ryP	M2K5U\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
L-363	MoTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M4rsNmlEPTB;ND63O\|EyPiEQvF2=	MkXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
MEL-HO	M33Ec2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NID3bpNKSzVyPUSuO\|c6QDlizszN	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
TYK-nu	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NIfiZmxKSzVyPUSuPFAyOjhizszN	M2rQ[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
MDA-MB-415	NV:3[WlST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M4\MNmlEPTB;NT6wNFMyPCEQvF2=	MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HCC70	M2K2VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MYnJR\|UxRTVwMEO5N\|kh\|ryP	NEf4Zos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
IGROV-1	M3LMUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M2DYNGlEPTB;NT6yOVI6OiEQvF2=	Mn;LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H1355	Mlv2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NVXQWJdYUUN3ME21MlI6PiEQvF2=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
23132-87	NVXUWWxKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MWjJR\|UxRTVwM{KwNlQh\|ryP	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NB69	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MYfJR\|UxRTVwM{K0NkDPxE1?	NHHKO5o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HSC-2	NU[0NWhpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MkPCTWM2OD13LkSxO\|c{KM7:TR?=	NH\YfoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
KYSE-410	M17QZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MUHJR\|UxRTVwNEe2N\|Yh\|ryP	NV3XclRIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
GCIY	MlvRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NFOyUmtKSzVyPUWuOVE{PzhizszN	M4HSRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
A427	NIDOepFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NFPGdVFKSzVyPUWuOVM3PjFizszN	Mn\JQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
ChaGo-K-1	M{LtVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			Ml;ETWM2OD13LkW2OVk6KM7:TR?=	NUO3XWQ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
PFSK-1	NXi2d2RXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NEDiWnZKSzVyPUWuOlIyQTRizszN	NIO3U\|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
MLMA	M3vLW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NVXDUVBiUUN3ME21Mlg{PjB4IN88US=>	NF\Rb5A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
RVH-421	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MXPJR\|UxRTZwMEezN\|gh\|ryP	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LB1047-RCC	M4nrcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MXPJR\|UxRTZwMUe1NlIh\|ryP	NWXEVppCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MHH-NB-11	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NXTZSGNFUUN3ME22MlMzPzJzIN88US=>	MoPQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
J-RT3-T3-5	NGHkWGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MmLTTWM2OD14Lk[zNlkyKM7:TR?=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
UM-UC-3	NFrpR25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NXrQ[oE5UUN3ME22MlY1OzN2IN88US=>	MnfCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
IST-SL1	NVHDV4tNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Ml\3TWM2OD14Lk[5N\|Y6KM7:TR?=	Mk\RQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NB14	NXrCe2R4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NXXObJR7UUN3ME22Mlc6PzZzIN88US=>	MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NBsusSR	MnfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MVTJR\|UxRTZwOEK1NFIh\|ryP	NUfnbpZNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
D-263MG	NHfOeGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NUH2fnBQUUN3ME22MlkyODZ6IN88US=>	M3jI[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
NCI-H2347	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NXXXeHJjUUN3ME22Mlk{OjF\|IN88US=>	NWDjW\|l3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
ES8	Ml3KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MoXZTWM2OD14Lkm3OVg5KM7:TR?=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
786-0	NYnl[ZdIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mo\ITWM2OD15LkC5O\|g3KM7:TR?=	M1LoOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
EPLC-272H	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NIDU[2VKSzVyPUeuNVYzPDZizszN	M{DEV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
CAPAN-1	NFrId3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHHjOIdKSzVyPUeuNlQ{PTlizszN	NVT1c2F4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H82	NYTTeJBVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NYDIOJdWUUN3ME23MlI3PjV7IN88US=>	NWfrZ3VORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
G-402	M1TsXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MY\JR\|UxRTdwM{CwOVEh\|ryP	M4fTNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SW982	MorpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWnJR\|UxRTdwM{CyNFMh\|ryP	NITGb5g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
OVCAR-4	MkHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M{fKPWlEPTB;Nz6zNVMzQCEQvF2=	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KARPAS-299	NU[zRYF{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M2rHZ2lEPTB;Nz6zNlYzOiEQvF2=	NUX2dYYyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MIA-PaCa-2	NELFW25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MUPJR\|UxRTdwM{[4NlMh\|ryP	NF7INFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
AU565	M{TNZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmrPTWM2OD15LkW5PFM{KM7:TR?=	Mm\IQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
GAMG	NYLiU4pPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M3v3b2lEPTB;Nz62OFE{OSEQvF2=	NVrTUmQ{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HuO9	M{TCd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M2TW[mlEPTB;Nz63NVc1OyEQvF2=	M4TuW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
ACN	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NH;TS41KSzVyPUeuO\|Q{OyEQvF2=	MlvUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
RO82-W-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MYXJR\|UxRTdwN{S1N\|Mh\|ryP	NI\4[GY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
NKM-1	NUfEdGxUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M4Tvc2lEPTB;Nz63OFk2PSEQvF2=	NVPCWVB5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
CAL-12T	M3HRXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NXu2dmcxUUN3ME23Mlk1OzV{IN88US=>	NELSNWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
FADU	MkG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHHSTphKSzVyPUiuNFM3PTRizszN	MkPUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H28	M3TvN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M1LEe2lEPTB;OD6xOlk3OiEQvF2=	NVjW[\|lxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
LCLC-97TM1	MoHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M4TKOWlEPTB;OD6yNVEzOiEQvF2=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
CHP-134	MnzSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NUfaNW5uUUN3ME24MlI1OTh3IN88US=>	NGXIeIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HT-1080	Ml3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHrXR2JKSzVyPUiuNlUxQTNizszN	MmLlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
PC-3	M1fOPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MkLXTWM2OD16LkK3N\|kzKM7:TR?=	Ml;vQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SNU-449	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MVLJR\|UxRThwMke5N{DPxE1?	M{HPUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
VA-ES-BJ	NGjoSm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MnXCTWM2OD16LkO0Olg3KM7:TR?=	NFnafmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HT	NGKyfVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NX;wUZlkUUN3ME24MlM3PDlizszN	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HOS	Mn7RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MVrJR\|UxRThwM{e1PFkh\|ryP	NX76S4RCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
KNS-62	NUnOXIs3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MoTLTWM2OD16LkO3O\|YzKM7:TR?=	NHvxSGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
OAW-42	NIToSVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MkXOTWM2OD16Lkm1PVY1KM7:TR?=	M323XlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
A549	NF\CZlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M2HCXmlEPTB;OT6wPVYyOiEQvF2=	M3rKbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
CAKI-1	M1LBN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MX\JR\|UxRTlwMU[2NUDPxE1?	NXm5Wpl{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HCC1937	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M1LnV2lEPTB;OT62PVg3PSEQvF2=	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
GI-ME-N	M32yR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MVzJR\|UxRTlwN{CxN\|ch\|ryP	Mn;kQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
DU-4475	MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MV3JR\|UxRTlwOU[5N\|kh\|ryP	NFq3XY09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
EM-2	NHLB[ZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NFPnfVBKSzVyPUGwMlI1OjZizszN	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H1755	NWO3d2JkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NWHINY5kUUN3ME2xNE4zPDJ6IN88US=>	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H1437	NH[yUFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MV;JR\|UxRTFyLkW3NlUh\|ryP	NXnkd2x1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
VM-CUB-1	M4fQXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MoLWTWM2OD1zMD62NVY1KM7:TR?=	M1PuN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
A2058	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NYPrZ\|dkUUN3ME2xNE43PDB2IN88US=>	M4DJOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
BPH-1	M{\Cc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NWfUUmJTUUN3ME2xNE44OTR3IN88US=>	M{LvSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
NB5	M3X6[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NXf0SWlSUUN3ME2xNE44PTV7IN88US=>	M3rGVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
G-401	NYrzZWN7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mm\xTWM2OD1zMD63OlI3KM7:TR?=	NXnT[mNjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
CAL-72	M1i4W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NX7VO\|FmUUN3ME2xNE45ODl2IN88US=>	MoXlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SK-MEL-28	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MUDJR\|UxRTFyLkiyNFIh\|ryP	NFjnSm09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
C32	NX7GWHF[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mk[0TWM2OD1zMD64N\|Q4KM7:TR?=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H1155	M3vmNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MUPJR\|UxRTFyLkizO\|Yh\|ryP	M{fNfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
BB49-HNC	M{fidmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MWHJR\|UxRTFyLki1PFYh\|ryP	Mlq5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
GMS-10	MnzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MV3JR\|UxRTFyLki5O\|Eh\|ryP	NF\ISVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
K5	M2q0Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M4mxTmlEPTB;MUCuPVA4OSEQvF2=	NWLiOYFURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
OS-RC-2	NY\JeXlVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MnLDTWM2OD1zMT6wOVU6KM7:TR?=	NX\obJVmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HTC-C3	NEPUdXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MVLJR\|UxRTFzLkC3NVQh\|ryP	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LB996-RCC	NGG4e5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MmXUTWM2OD1zMT6wO\|I{KM7:TR?=	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H1563	NFT6TpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NXL0XIM2UUN3ME2xNU4yODFzIN88US=>	NUX5N5AxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
CAL-54	NFTMd\|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHL3UFFKSzVyPUGxMlQ5OTFizszN	NEHEcFg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
WM-115	M4n6UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MXHJR\|UxRTFzLk[4NlQh\|ryP	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
COLO-684	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NFq1[2ZKSzVyPUGxMlczPjdizszN	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HOP-62	NH\QS4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NFG3UoVKSzVyPUGxMlc2ODhizszN	NESxUWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
NCI-H650	MoTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NXvpSXhRUUN3ME2xNU45QTZzIN88US=>	NVK5U\|R[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
TE-11	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NFvsXGtKSzVyPUGxMlk{OTVizszN	NVfoc\|JQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
COLO-679	NUPXVZg{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MUjJR\|UxRTFzLkm0OkDPxE1?	Moi5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
FTC-133	NHXHcnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M4XqWWlEPTB;MUKuNFA4PiEQvF2=	MnLyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
D-283MED	NXPxWY9ET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MYLJR\|UxRTF{LkC1Olkh\|ryP	M1S3U\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SK-PN-DW	NXz4fogzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M1\MR2lEPTB;MUKuNVkxOiEQvF2=	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
BALL-1	NX7EfnI4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M1HVb2lEPTB;MUKuNlY3OiEQvF2=	MmXKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
GT3TKB	NFzOdZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MlizTWM2OD1zMj6zNFc1KM7:TR?=	M{WydFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
HOP-92	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M2HJW2lEPTB;MUKuOVI{OyEQvF2=	NYD0dotKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
M14	M{fJe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M{Hu[mlEPTB;MUOuNFM{PSEQvF2=	M2nhe\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SKG-IIIa	NEnTc2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MWXJR\|UxRTF\|LkC1OVQh\|ryP	NEXvRoc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
Becker	NFvqdWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M{fYNGlEPTB;MUOuNFU5KM7:TR?=	MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
ES5	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M1;jdGlEPTB;MUOuNVM2PiEQvF2=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H2030	NGr5SINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHPU[ZRKSzVyPUGzMlIxPjJizszN	NFXINo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SNU-423	MnrHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MXfJR\|UxRTF\|LkO4NUDPxE1?	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
CP50-MEL-B	M3\nbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MWHJR\|UxRTF\|Lk[yN\|Ih\|ryP	MlzMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H1092	MmTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWPJR\|UxRTF\|Lke0O\|Uh\|ryP	NFK4eXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
8-MG-BA	NHvTTWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M4HsPGlEPTB;MUOuO\|UyOyEQvF2=	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
CAL-27	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MmTuTWM2OD1zND6wO\|I4KM7:TR?=	NXLEXlJ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
AGS	M3izWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmXXTWM2OD1zND6xN\|E6KM7:TR?=	NVy4fFRvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MZ2-MEL	Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M3fnSGlEPTB;MUSuNVQ5QCEQvF2=	NGW4b3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
BFTC-909	M33Wemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NHztPGRKSzVyPUG0MlUxPTVizszN	NVzwfoVyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
D-566MG	NHvXVVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NF3OdnJKSzVyPUG0Mlc4ODZizszN	Ml;5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
MZ7-mel	M37tR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NHzXRYFKSzVyPUG1MlExPjdizszN	MljVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
TE-5	NUDWUGpmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NF63ZZdKSzVyPUG1MlI{OzNizszN	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
647-V	NH;CVldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHXWV4lKSzVyPUG1MlI4ODVizszN	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
DMS-114	M1\3Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NVXoOXY2UUN3ME2xOU4{OjlzIN88US=>	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
ME-180	NWrJ[pFkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MVPJR\|UxRTF3LkS3PFMh\|ryP	M3PvS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
MS-1	NEnXcIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NUe0ZWdbUUN3ME2xOU42PjJ\|IN88US=>	MkjWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NUGC-3	NWLEXIs5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M{LJUGlEPTB;MUWuOlI1PSEQvF2=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
GB-1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MVjJR\|UxRTF3Lk[0N\|ch\|ryP	M3vMW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LOXIMVI	MnL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M1PaWGlEPTB;MUWuPFkyQSEQvF2=	NUjBeFFQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H1304	Ml24S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MX3JR\|UxRTF3Lki5Nlgh\|ryP	NWDydXNZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
KURAMOCHI	M4S2bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NITZNVBKSzVyPUG1Mlk4OSEQvF2=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
SW1783	MmDnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M1vWZmlEPTB;MU[uNFk6OyEQvF2=	NGj2N4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
EGI-1	NU[xU25jT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NGnFenRKSzVyPUG2MlU{PjVizszN	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KGN	NVnrfYZHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MV\JR\|UxRTF4LkW1PFYh\|ryP	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
PANC-03-27	NIXySItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M2[yeGlEPTB;MU[uO\|Y3OiEQvF2=	MkTyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
RH-1	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NIDqR4xKSzVyPUG2MlgzPSEQvF2=	NUS1RVFSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HT-1376	MnrkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M3jt[mlEPTB;MU[uPFQ1PiEQvF2=	Mn;CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
ZR-75-30	NFnmWJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NGe3[FhKSzVyPUG2Mlk{PjFizszN	M1jZSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
TI-73	NVrF[Y9bT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Mn\KTWM2OD1zNj65OFA5KM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
TK10	MkOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M1yxc2lEPTB;MUeuNFA4QSEQvF2=	M37peFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SW684	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MlXtTWM2OD1zNz6wNVU1KM7:TR?=	NFj2UnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
RPMI-8866	M3G4PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NGTGTYZKSzVyPUG3MlA3QTlizszN	M4nXV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LNCaP-Clone-FGC	MmTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NX76[XVWUUN3ME2xO{42OjBzIN88US=>	NXe1fJJIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H2291	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M1\qNWlEPTB;MUiuOFM1PSEQvF2=	NVHKb5dsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
T47D	NH\zRnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NYLyTo9WUUN3ME2xPE41QDhizszN	NWCxdoN4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
A204	M1XLUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NX\zfI9KUUN3ME2xPE42PDV{IN88US=>	M365fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
HT-144	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MkfiTWM2OD1zOD63OFI4KM7:TR?=	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
MDA-MB-361	M{\6T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M2n2fWlEPTB;MUmuNFcyPCEQvF2=	NGLQVoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HCC1806	NY\yNoFIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NUjIb3JnUUN3ME2xPU4yPTlzIN88US=>	NFLtN5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
NCI-H596	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NYnKdHlpUUN3ME2xPU43OzlzIN88US=>	NFPYXII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
K-562	NHHRU\|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NGjaNZpKSzVyPUG5Mlg6OjZizszN	MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
D-336MG	NVjXfpZlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MVvJR\|UxRTF7LkmzNlIh\|ryP	MkfGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SK-MEL-2	MnHIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NX7uXFV3UUN3ME2yNE4yPTV7IN88US=>	NGKzPVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HEC-1	M4myZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			Ml60TWM2OD1{MD60PVc5KM7:TR?=	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
EW-13	Mlq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NYn0RZRYUUN3ME2yNE42PDR\|IN88US=>	NXjzNG83RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
Hs-578-T	M1XUOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M4qzc2lEPTB;MkCuOVU5OyEQvF2=	M12wT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SJSA-1	MnjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHfOd45KSzVyPUKwMlU3QDhizszN	M1TIWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
RCC10RGB	MoHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M3vWRmlEPTB;MkCuOlcyQSEQvF2=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LAN-6	Ml7HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MnmyTWM2OD1{MT6wN\|k3KM7:TR?=	NWrSfIxkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H1048	M{\2PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M3rJ[mlEPTB;MkGuNlI2QCEQvF2=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
CW-2	NGDrXHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MnzBTWM2OD1{MT6yO\|A2KM7:TR?=	NWLsXo9VRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HCC2157	Ml\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M3jsTWlEPTB;MkGuN\|Yh\|ryP	M3m0dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
EW-22	M2\FR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M{jiOWlEPTB;MkGuN\|c3KM7:TR?=	NWD1WnlxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
A253	M{ewZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NIHUbHNKSzVyPUKxMlQ1QDFizszN	Ml7yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
BE-13	M3z6Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M3nCO2lEPTB;MkGuOlEyOyEQvF2=	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KINGS-1	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MVPJR\|UxRTJzLk[zNVYh\|ryP	NYDOVYhXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
ETK-1	MnPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			Mkf4TWM2OD1{MT64NVUzKM7:TR?=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H2452	MoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MXXJR\|UxRTJzLki2OFch\|ryP	NHzhSFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HPAF-II	NUHu[XBsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M3\pcGlEPTB;MkGuPFkzOyEQvF2=	NGrVNVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
D-542MG	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MojBTWM2OD1{MT65NFY6KM7:TR?=	NULNO5hZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H630	NGfKZplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M{\iOGlEPTB;MkKuNFI6PiEQvF2=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
TGBC11TKB	M1m1e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmrPTWM2OD1{Mj6wOFkh\|ryP	NIr4TXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
BCPAP	NWLSOY8zT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NG\5XWdKSzVyPUKyMlYyOSEQvF2=	NU\T[HpqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
HLE	NHu2dpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHnie3lKSzVyPUKyMlY6PyEQvF2=	NXi1XYZORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H727	NX;Bd3JXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NV65ToJlUUN3ME2yNk44OzVizszN	NYXwRnN3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
RD	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MkHYTWM2OD1{Mj63OVE5KM7:TR?=	NXnLVG1tRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H522	M3LEOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M2rqdGlEPTB;MkKuPFQ{OSEQvF2=	MmmwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
CGTH-W-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NHW2S4NKSzVyPUKzMlA3PDFizszN	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
SK-LU-1	M{DHTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NEDYPFRKSzVyPUKzMlQ3QDNizszN	M1PtSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
BB65-RCC	NV;yUHRiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NXvtVmJmUUN3ME2yN{44QDZ\|IN88US=>	NIjxTlg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HSC-3	MkPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M175fGlEPTB;MkOuPFUzPyEQvF2=	NEC5W2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SK-MES-1	M2TTUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			Ml;rTWM2OD1{ND6wNVYyKM7:TR?=	MmOyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
DB	M37SUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MX;JR\|UxRTJ2LkGwNlgh\|ryP	M4DieVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
HO-1-N-1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M2HoUGlEPTB;MkSuN\|A6OyEQvF2=	NVjjZ4xoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MKN1	MlnJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M1S4bmlEPTB;MkSuOlgh\|ryP	MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
MN-60	NXvQ[GpmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MnTUTWM2OD1{ND64OVE6KM7:TR?=	M37sVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
8505C	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NF[xcnFKSzVyPUK1MlE5PDVizszN	M4fITVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
COLO-320-HSR	MlzTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NIPvUJdKSzVyPUK1MlIzODhizszN	MnjYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
BB30-HNC	NH\6PW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M13ycGlEPTB;MkWuNlQ5OyEQvF2=	NID2Soo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
KM12	NIDrfHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NEL2RnJKSzVyPUK1MlU5ODdizszN	NYXEZ\|I5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NB13	NHjtSoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NWjDclAzUUN3ME2yOU42QDl6IN88US=>	MlXzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
HCC2998	NUHoPVF{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NYf3bWdXUUN3ME2yOk4xOjh\|IN88US=>	NX3P[HV6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
U-118-MG	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NX;DPGVEUUN3ME2yOk4xQDB6IN88US=>	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NB10	NUW4fIx1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MUPJR\|UxRTJ4LkKzOEDPxE1?	NETSc5Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SK-LMS-1	NYnzT2ZwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NXmwRW5IUUN3ME2yO{4xPzB2IN88US=>	MoD2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SW1573	M4P2c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			M4n3cWlEPTB;MkeuNVEh\|ryP	M3vrU\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
LB373-MEL-D	NGXleHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MVPJR\|UxRTJ5LkGyPVQh\|ryP	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
DK-MG	NFTzfmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MWDJR\|UxRTJ5LkG4NVch\|ryP	MoK5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
RMG-I	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M{Di[mlEPTB;MkeuNlAzQSEQvF2=	M{ewZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SW1088	M{PM[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MVLJR\|UxRTJ5LkWwOFIh\|ryP	NFzvT4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SK-OV-3	M4jMSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MX3JR\|UxRTJ5Lke1PVMh\|ryP	NYHaWYVERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
KP-N-YN	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MXHJR\|UxRTJ5LkiwOFMh\|ryP	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
RPMI-7951	M1Sx[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MX3JR\|UxRTJ6LkK0OVYh\|ryP	NHKwWpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
CaR-1	NWHNXoZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MnTqTWM2OD1{OD61OVgzKM7:TR?=	NHGwTXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
MKN7	M4PYN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmTrTWM2OD1{OD61PVY1KM7:TR?=	M4i4WVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
CHP-212	NVviNGx[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MWHJR\|UxRTJ6Lke0NFEh\|ryP	M3HkO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
KYSE-450	M2jlOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MXPJR\|UxRTJ6LkiwPVEh\|ryP	NGjTO4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
RXF393	Mny4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWLJR\|UxRTJ7LkK5NFYh\|ryP	NV\1NFZMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
P30-OHK	MoLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M2m2bmlEPTB;MkmuN\|A1QCEQvF2=	NHTTW3M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
Ca9-22	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MmL2TWM2OD1{OT60Nlk6KM7:TR?=	MkftQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
RT-112	NF7McldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NVSzW4F3UUN3ME2yPU41PjFzIN88US=>	NVHaSWh6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
ES1	MnvJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MlXWTWM2OD1{OT64OVQ1KM7:TR?=	NIjUSoQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HCE-4	NHr3OWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MlyzTWM2OD1{OT64O\|g3KM7:TR?=	NGm1[G09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
AM-38	Moj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NIPLXJRKSzVyPUOwMlA3ODZizszN	M{mxeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
AsPC-1	NH20ZYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MXjJR\|UxRTNyLkiwOVMh\|ryP	M2\G[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
TE-9	Ml2zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWLJR\|UxRTNyLki3N\|ch\|ryP	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
HuP-T4	M{iwUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NEL0XppKSzVyPUOwMlk3OzhizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LB2518-MEL	MlvzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MUHJR\|UxRTNzLkC3OFQh\|ryP	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
NCI-H1703	NVLNfWE6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NIrm[mhKSzVyPUOxMlA6ODVizszN	MkfkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H2228	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MXnJR\|UxRTNzLkS2OVEh\|ryP	Mn;yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SCC-4	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MmHmTWM2OD1\|MT65NVgyKM7:TR?=	NVTFWFZvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
KNS-81-FD	Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MWnJR\|UxRTN{LkCxNlgh\|ryP	NX;sZpByRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NTERA-S-cl-D1	M3izSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NIX5T4lKSzVyPUOyMlA4OzlizszN	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
Daoy	NUfM[oVmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MmDMTWM2OD1\|Mj6wPFM5KM7:TR?=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
ES4	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M3HYb2lEPTB;M{KuN\|kzOiEQvF2=	NVS0UlZyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
MHH-ES-1	MnXvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MVLJR\|UxRTN{LkS4O\|Ih\|ryP	NFuwdoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
C-33-A	NYrOTJJDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MVjJR\|UxRTN{Lke3Nlgh\|ryP	NVTPNZZlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
BHY	M1TRdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NIK1THlKSzVyPUOyMlk1QTVizszN	MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
Detroit562	NXq5ZlVST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M3TrN2lEPTB;M{OuOlY2PyEQvF2=	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
EW-1	Mmf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M1KweWlEPTB;M{OuPVMzOiEQvF2=	MlrBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H1395	NX;ZT5dWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M1rzcGlEPTB;M{SuNFc6QSEQvF2=	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KM-H2	MkPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHfBVmNKSzVyPUO2MlQ4PDNizszN	MmnRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
NCI-H520	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M3fyVmlEPTB;M{[uO\|U1OSEQvF2=	NV\XU49RRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
D-392MG	NVOwSIZsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M174V2lEPTB;M{euN\|M1PCEQvF2=	M2OwUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
NOMO-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MkHVTWM2OD1\|Nz64NFg6KM7:TR?=	NIjld\|U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
TE-6	NYXUXIdQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MmfTTWM2OD1\|OD6xNlQh\|ryP	M1;qZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
HT-3	NVzRVWl5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MVXJR\|UxRTN6LkS0N\|Yh\|ryP	M1XDSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
RPMI-8226	M3fUTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NYDYTVhOUUN3ME2zPE46PTF7IN88US=>	M2TZ[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
U251	NXKyVnl7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MUjJR\|UxRTN7LkCxNlQh\|ryP	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
GCT	M{\tT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MVHJR\|UxRTN7LkG4OVIh\|ryP	MlnjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
A431	MlPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MlfLTWM2OD1\|OT6xPFk1KM7:TR?=	NF3IVHY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
TE-12	NULPRog1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			M{XaUWlEPTB;M{muNlQ1QCEQvF2=	Mn;yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
HMV-II	NESxNGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MXnJR\|UxRTN7LkWwOFch\|ryP	M{TTZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
IST-MES1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NH;yV5FKSzVyPUSwMlE2ODJizszN	Ml3aQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SW13	M4D0[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NYrmeVh5UUN3ME20NE42OTlizszN	M365[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
SF295	NX[zeItUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NHrIUVNKSzVyPUSwMlgxPjZizszN	Mo\TQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
MDA-MB-157	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MlHWTWM2OD12MD65OFYzKM7:TR?=	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
TE-1	NUnvNXF5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MmrxTWM2OD12MT64O\|E1KM7:TR?=	NEDJWWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HuCCT1	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NXHpeHM5UUN3ME20Nk42Ojh7IN88US=>	M4rBbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
KYSE-510	M2jTVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NIi0W4hKSzVyPUSzMlE4PTRizszN	M1uyXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
NCI-H358	MkXlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MYXJR\|UxRTR2LkCzNFQh\|ryP	MnXTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
SW900	NFjNdYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			NHjxUpRKSzVyPUS0MlA4PThizszN	NWTxbmp6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
CAS-1	NWC4fm5PT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MVjJR\|UxRTR2LkC5PVEh\|ryP	MkPHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
TE-8	NV72bVhkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Ml3BTWM2OD12ND61OlU5KM7:TR?=	NF;4Ro49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
P12-ICHIKAWA	NW\ZOWY5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NIHXb5BKSzVyPUS0MlYyOTJizszN	Mn62QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
YKG-1	MknQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M2LsZ2lEPTB;NESuO\|gyKM7:TR?=	NGm0elM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SNU-C2B	NWT0NVlpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NFuyPG9KSzVyPUS0Mlc6ODNizszN	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
LCLC-103H	NVnRNXRxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NWPDS\|NyUUN3ME20OE45PzB\|IN88US=>	M{O3XVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
U-87-MG	Mn3yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MmPxTWM2OD12NT6xNFIzKM7:TR?=	NGTVTpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
HAL-01	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NH7zfpVKSzVyPUS1MlE{PzlizszN	M{\kN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QDZ5OD:nQnNCVkeHUkyvZV4>
OVCAR-8	NUfMXms{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MYHJR\|UxRTR3LkO1OlQh\|ryP	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
KYSE-150	NVnGeXliT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NWDCV5pVUUN3ME20O{4yODV{IN88US=>	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
OE33	NHrXRZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			MnzyTWM2OD12Nz6xOFI6KM7:TR?=	MkL6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
CAL-62	M4W1Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NETlSXFKSzVyPUS3MlQxPjhizszN	NE\RO2s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
TCCSUP	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MlS2TWM2OD12Nz62NlY1KM7:TR?=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
H4	M1G2bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MmPJTWM2OD12Nz62OlIyKM7:TR?=	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
CP66-MEL	M1Hxcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			Mnn4TWM2OD12OD6wO\|A1KM7:TR?=	NFvxc4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
SNB75	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			MVvJR\|UxRTR6LkG4O\|Qh\|ryP	MlTHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
Mo-T	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			NFP4ZYhKSzVyPUS4MlI4QSEQvF2=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFg3PzhxJ{7TRW5ITVJ:L3G+
BT-549	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M1fPXGlEPTB;NEiuN\|czQSEQvF2=	NITCWGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDh4N{ivK\|5USU6JRWK8M4E,
IGR-1	M162S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7			MoXITWM2OD12OD62OlQ2KM7:TR?=	NWrISVdiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh6Nke4M{c,W0GQR1XSQE9iRg>?
NCI-H1299	MnvPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			MUHJR\|UxRTR6LkeyOFgh\|ryP	Mn;3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
ALL-PO	MmfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			M2WyN2lEPTB;NEmuPVI3QCEQvF2=	MnvRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg5Pjd6Lze+V2FPT0WUPD;hQi=>
CLL	MYnGeY5kfGmxbjDhd5NigQ>?			MUHJcohq[mm2aX;uJI9nKESQQT3QT{BifXSxcHjvd5Bpd3K7bHH0bY9vKGG2IGPldlIxPTZicnXzbYR2\SCrbjDoeY1idiCFTFygZ4VtdHNiYomgW4V{fGW{bjDicI91KG2ndHjv[EwhUUN3MDC9JFAvODNizszNMi=>	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh\|NUi3NEc,OjJ6M{W4O\|A9N2F-
HeLa	NVrVVIN4TnWwY4Tpc44h[XO\|YYm=			MlrHTY5pcWKrdHnvckBw\iCGTlGtVGsh[XW2b4Doc5NxcG:{eXzheIlwdiCjdDDTNlA2PiCrbjDoeY1idiCKZVzhJINmdGy\|LDDFR\|UxKD1iMD6yNVIh\|ryPLh?=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh3NUizOkc,OjN6NUW4N\|Y9N2F-
CHO	NX3aenpNTnWwY4Tpc44h[XO\|YYm=			MV;Jcohq[mm2aX;uJI9nKGi3bXHuJGVTTyCneIDy[ZN{\WRiaX6gZ4l{[XC{aXTlJJRz\WG2ZXSgR2hQKGOnbHzzJIJ6KEmxbjDXc5JseyCjc4PhfUwhUUN3MDC9JFE1KM7:TT6=	NEXqN3Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i1OVg{Pid-MkO4OVU5OzZ:L3G+
A673	M3f2fZFJXFNiYYPzZZk>			NUPINJFGeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IFG2O\|Mh[2WubIO=	M4DndlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
DAOY	Mlf4dWhVWyCjc4PhfS=>			NVTj[WhyeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO=	MkC0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
Saos-2	Mk\EdWhVWyCjc4PhfS=>			NXLDTolseUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IGPhc5MuOiClZXzsdy=>	M{T0bVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-37	MlXMdWhVWyCjc4PhfS=>			MmnidWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUO3JINmdGy\|	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
RD	MXrxTHRUKGG\|c3H5			MoPUdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{	MmXFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
BT-12	NGXSeZJyUFSVIHHzd4F6			NYLBV\|NKeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IFLUMVEzKGOnbHzz	NHW1bXU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
MG 63 (6-TG R)	NULPTZpzeUiWUzDhd5NigQ>?			NGT4U2ZyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTVegOlMhMDZvVFegVkkh[2WubIO=	NF64RmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
NB1643	M2LXVJFJXFNiYYPzZZk>			M2LXRpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQkG2OFMh[2WubIO=	NIHDZlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
OHS-50	M1zYOZFJXFNiYYPzZZk>			MXjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy\|	NU[0VFdjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
SJ-GBM2	MYnxTHRUKGG\|c3H5			MVPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?=	NFnwT2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
SK-N-MC	NU\SN3JveUiWUzDhd5NigQ>?			NHr1THdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1OSyClZXzsdy=>	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
NB-EBc1	M1r3OJFJXFNiYYPzZZk>			M4TCZpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQj3FRoMyKGOnbHzz	M3:zS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5	Mlf5dWhVWyCjc4PhfS=>			MVTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVEGQLUWgZ4VtdHN?	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
Rh18	NX21fGZweUiWUzDhd5NigQ>?			M3HmNZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEG4JINmdGy\|	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
INA-6	MVvGeY5kfGmxbjDhd5NigQ>?	MYKxNEB2VQ>?	NYLwOWhyPCCqcoO=	NVTOc3NmUW6qaXLpeIlwdiCxZjDo[YF1KHOqb3PrJJJme3CxboPlJIlvKGi3bXHuJGlPSS14IHPlcIx{KGG\|c3Xzd4VlKGG\|IILl[JVkfGmxbjDpckBJW0ZvMTDt[YRq[XSnZDD1dJJm\3WuYYTpc44hd2ZidHjlJGhUWDd{IIDyc5RmcW5iZYjwdoV{e2mxbjDheEAyOCC3TTDwdoVqdmO3YnH0[YQh\m:{IESgbJJ{KG[xbHzve4VlKGK7IFjTVFkxKGmwaHnibZRweiCjbnSgTHNTKGmwZIXj[ZIhVl[SLVHVXVkzOiCjZHTpeIlwdiCvZXHzeZJm\CCjZoTldkA1KGi{	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3M{mzNUc,Ojh2NUO5N\|E9N2F-
INA-6	NGT4VZVHfW6ldHnvckBie3OjeR?=	NHfNUnEyOCC3TR?=	M{e5SlQhcHK\|	NGjyNI5KdmirYnn0bY9vKG:oIHjlZZQhe2ixY3ugdoV{eG:wc3WgbY4hcHWvYX6gTW5CNTZiY3XscJMh[XO\|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJGhUTi1zIH3l[IlifGWmIIXwdoVofWyjdHnvckBw\iC2aHWgTHNRPzJibWLORUBmgHC{ZYPzbY9vKGG2IEGwJJVOKHC{ZXnuZ5Vj[XSnZDDmc5IhPCCqcoOg[o9tdG:5ZXSgZpkhUFOSOUCgbY5pcWKrdH;yJIFv\CCKU2KgbY5lfWOncjDOWnAuSVW\OUKyJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IESgbJJ{KGJ?	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3M{mzNUc,Ojh2NUO5N\|E9N2F-
INA-6	M1rRSGZ2dmO2aX;uJIF{e2G7	M2rBW\|ExKHWP	M2KwTVQhcHK\|	MojsSI94dnKnZ4XsZZRqd25ib3[gUnZRNUGXWUmyNk1qdmS3Y3XkJGhUTi1zIIDyc5RmcW5iZYjwdoV{e2mxbjDpckBpfW2jbjDJUmEuPiClZXzsd{BifCBzMDD1UUBxemWrbnP1ZoF1\WRiZn;yJFQhcHK\|IH\vcIxwf2WmIHL5JG5XWC2DVWm5NlIh[WSmaYTpc44hdWWjc4Xy[YQh[W[2ZYKgOEBpenNiYomgW4V{fGW{bjDicI91KG2ndHjv[C=>	Ml7xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUO5N\|EoRjJ6NEWzPVMyRC:jPh?=
INA-6	NUPuboVbTnWwY4Tpc44h[XO\|YYm=	MoPBNVAhfU1?	M{XIdFQhcHK\|	NYPmXZo1UW6qaXLpeIlwdiCxZjDOWnAuSVW\OUKyMYlv\HWlZXSgTHNHNTFicHjvd5Bpd3K7bHH0bY9vKGmwIHj1cYFvKEmQQT22JINmdGy\|IHH0JFExKHWPIIDy[Ylv[3WkYYTl[EBnd3JiNDDodpMh\m:ubH;3[YQh[nliTm\QMWFWYTl{MjDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB2IHjyd{BjgSCZZYP0[ZJvKGKub4SgcYV1cG:m	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3M{mzNUc,Ojh2NUO5N\|E9N2F-
INA-6	NXTKNnZoTnWwY4Tpc44h[XO\|YYm=	NWLBbmh2OTBidV2=	MlXyOEBpenN?	NGjsVFBFd3ewcnXneYxifGmxbjDv[kBPXlBvQWXZPVIzNWmwZIXj[YQhUFOILUGgcXJPSSCneIDy[ZN{cW:wIHnuJIh2dWGwIFnORU03KGOnbHzzJIF1KDFyIIXNJJBz\WmwY4XiZZRm\CCob4KgOEBpenNiZn;scI94\WRiYomgUnZRNUGXWUmyNkBi\GSrdHnvckBu\WG\|dYLl[EBi\nSncjC0JIhzeyCkeTDSWE1RS1JibXX0bI9l	MoqzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUO5N\|EoRjJ6NEWzPVMyRC:jPh?=

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	p-DNA-PKcs / DNA-PKcs / p-ATM / ATM / p-ATR / ATR / Ku70 / p-CHK1 / p-CHK2/ p-AKT / RAD51; PubMed: 29344644 Oncol Rep SUNE1 cells were irradiated with 5 Gy in the presence or absence of NU7441 (2 µM). The expression of cell cycle checkpoint proteins and double strand break repair proteins was assayed by western blot analysis at 6 or 12 h post-IR. p-mTOR(Ser2448) / mTOR / p-S6K(Thr389); PubMed: 25714019 Oncotarget Phosphorylation of mTOR and p70S6K were detected by Western blot analysis 24 hours after treatment.	29344644 25714019

体内研究

NU7441按 10 mg/kg剂量腹腔注射处理携带SW620移植瘤的小鼠，按无毒剂量处理至少4小时，然后提高 Etoposide诱导的肿瘤生长延迟2倍。 ^[2]

细胞实验： ^[2]	- 合并 Cell lines: SW620, LoVo, V3-YAC和 V3细胞 Concentrations: 0.5 μM或 1 μM Incubation Time: 17 小时 Method: 通过克隆实验测定NU7441，Etoposide, Doxorubicin, 和电离辐射作用于SW620, LoVo, V3,和 V3-YAC细胞存活的效果。在有或无 NU7441(0.5 或 1.0 μM)存在时，使用Etoposide 或Doxorubicin处理6孔板或6-cm盘中指数生长的细胞16小时。放射增敏研究中， NU7441加到细胞中，1小时后，使用辐射处理。使用γ-射线 (3.1 Gy/min ¹³⁷Cesium)处理V3和V3-YAC 细胞。使用可用设备，使用X-射线 (2.9 Gy/min at 230 kV, 10 mA) 处理SW620 和 LoVo 细胞。辐射处理后，在有或无NU7441存在时，细胞再温育16小时。胰蛋白酶消化，收集细胞，计数，然后按每盘 100 到10⁵ 的密度接种在10-cm 直径的Petri盘中，盘中含无药物培养基，用于形成集落。使用结晶紫对集落进行染色，10 到 14天后，使用自动集落计数器计数。 (Only for Reference)
动物实验： ^[2]	- 合并 Animal Models: 携带 SW620移植瘤的雌性裸鼠 Dosages: 10 mg/kg Administration: 腹腔注射 (Only for Reference)

参考文献

- 合并

溶解度 (25°C)

体外	DMSO	4 mg/mL warmed (9.67 mM)
	Water	Insoluble
	Ethanol	Insoluble
体内	从左到右依次将纯溶剂加入产品，现配现用(数据来自Selleck实验检测而非文献)： 5% DMSO+40% PEG 300+5% Tween 80+50% ddH2O	0.5mg/mL

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据 Download NU7441 (KU-57788) SDF

分子量	413.49
化学式	C₂₅H₁₉NO₃S
CAS号	503468-95-9
储存条件	3年-20°C 粉状 2年-80°C 溶于溶剂
别名	N/A

动物体内配方计算器 (澄清溶液)

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO+ % + % Tween 80+ % ddH₂O

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

质量

浓度

体积

分子量
=

×

×

*在配置溶液时，请务必参考Selleck产品标签上、SDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入输出 )

C1

V1

C2

V2
×

=

×

在配置溶液时，请务必参考Selleck产品标签上、SDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

分子量计算器

通过输入化合物的化学式来计算其分子量：

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

常见问题及建议解决方法

问题 1：
Could you please suggest formulations of the drug for in vivo injection?
回答：
We tested the following formulation for in vivo use, 4% DMSO+30% PEG 300+5% Tween 80+ddH2O up to 1mg/mL. It is a clear solution.
问题 2：
Previous aliquots were clear and colorless while this time, it becomes yellow when the powder was dissolved in DMSO? Could you advice on this?
回答：
Slight color variation due to different processing is normal and usually doesn't interfere with the function.

DNA-PK Signaling Pathway Map

DNA-PK Inhibitors with Unique Features

非特异性的DNA-PK抑制剂

PI-103 : DNA-PK, IC50=23 nM; p110α/β/δ/γ, IC50=2 nM/3 nM/3 nM/15 nM; mTOR, IC50=30 nM.
活性最高的DNA-PK抑制剂

PIK-75 : DNA-PK, IC50=2 nM.
最新的DNA-PK抑制剂

KU-0060648 : Dual inhibitor of DNA-PK and PI3Kα, PI3Kβ, PI3Kδ with IC50 of 8.6 nM and 4 nM, 0.5 nM, 0.1 nM respectively, less inhibition of PI3Kγ with IC50 of 0.59 μM.
经典的DNA-PK抑制剂

NU7026 : Potent DNA-PK inhibitor with IC50 of 0.23 μM, 60-fold selective for DNA-PK than PI3K and inactive against both ATM and ATR.

研究领域

产品类型

定制您的化合物库

NU7441 (KU-57788)

客户使用Selleck生产的NU7441 (KU-57788)发表文献196篇：

产品安全说明书

DNA-PK抑制剂选择性比较

生物活性

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

参考文献

溶解度 (25°C)

化学数据 Download NU7441 (KU-57788) SDF

动物体内配方计算器 (澄清溶液)

计算器

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

稀释计算器

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

连续稀释计算器方程

连续稀释

计算结果

分子量计算器

总分子量：g/mol

摩尔浓度计算器

技术支持

常见问题及建议解决方法

DNA-PK Signaling Pathway Map

DNA-PK Inhibitors with Unique Features

相关DNA-PK产品